Published in Patient Relat Outcome Meas on September 17, 2010
Alexithymia and its impact on quality of life in a group of Brazilian women with migraine without aura. J Headache Pain (2013) 1.04
The psychometric properties of the persian migraine-specific quality of life questionnaire version 2.1 in episodic and chronic migraines. ScientificWorldJournal (2013) 0.91
White matter hyperintensities and self-reported depression in a sample of patients with chronic headache. J Headache Pain (2012) 0.88
Prevalence of migraine and co-morbid psychiatric disorders among students of Cumhuriyet University. J Headache Pain (2013) 0.82
Hearing voices: does it give your patient a headache? A case of auditory hallucinations as acoustic aura in migraine. Neuropsychiatr Dis Treat (2012) 0.75
A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine. Neurol Sci (2013) 0.75
The International Classification of Headache Disorders: 2nd edition. Cephalalgia (2004) 49.94
An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci (2005) 9.32
Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache (2001) 6.93
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 6.61
Cost of disorders of the brain in Europe. Eur J Neurol (2005) 6.41
Cost of lost productive work time among US workers with depression. JAMA (2003) 5.13
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med (2002) 4.86
Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2000) 4.86
Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA (1992) 4.77
Topiramate for migraine prevention: a randomized controlled trial. JAMA (2004) 3.13
Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev (2009) 3.00
Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache (1999) 2.61
Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology (1998) 2.60
Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A. Pain (2006) 2.58
Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol (2006) 2.25
The impact of migraine on quality of life in the general population: the GEM study. Neurology (2000) 2.24
Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol (2006) 2.23
The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol (1990) 2.19
Medication-overuse headache: a worldwide problem. Lancet Neurol (2004) 2.11
An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia (2000) 2.08
Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol (2007) 2.05
Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet (2007) 2.02
Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract (2005) 2.01
Occipital nerve stimulation for chronic headache--long-term safety and efficacy. Cephalalgia (2007) 1.91
Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol (2004) 1.83
A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache (2004) 1.82
Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol (1999) 1.80
Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia (2008) 1.74
Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA (2003) 1.73
Tension-type headache. Am Fam Physician (2002) 1.64
Migraine: preventive treatment. Cephalalgia (2002) 1.63
Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain (2009) 1.60
Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain (2003) 1.58
Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ (2001) 1.57
Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev (2004) 1.56
Efficacy of biofeedback in the treatment of migraine and tension type headaches. Pain Physician (2009) 1.56
Quality of sleep, fatigue and daytime sleepiness in migraine - a controlled study. Cephalalgia (2009) 1.53
Amlodipine for migraine prophylaxis. Headache (1998) 1.43
Measuring the functional status and well-being of patients with migraine headache. Headache (1994) 1.42
Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury. Pain (2006) 1.42
Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia (1992) 1.40
Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychiatry (1973) 1.31
A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology (2002) 1.27
Systematic reviews of complementary therapies - an annotated bibliography. Part 1: acupuncture. BMC Complement Altern Med (2001) 1.27
Propranolol for migraine prophylaxis. Cochrane Database Syst Rev (2004) 1.25
Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res (1993) 1.22
Basic mechanisms in vascular headache. Neurol Clin (1990) 1.19
Allodynia in migraine: association with comorbid pain conditions. Headache (2009) 1.19
Psychiatric comorbidity in chronic daily headache. Cephalalgia (1998) 1.16
Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Clin Ther (2009) 1.15
Medications for migraine prophylaxis. Am Fam Physician (2006) 1.14
Structure-function studies for the panacea, valproic acid. Biochem Soc Trans (2009) 1.12
The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin (1990) 1.07
Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol (2007) 1.06
Epidemiology of migraine. Biomed Pharmacother (1995) 1.06
New and future migraine therapy. Pharmacol Ther (2006) 1.05
Testing the combination beta-blocker plus topiramate in refractory migraine. Acta Neurol Scand (2007) 1.05
Understanding psychological stress, its biological processes, and impact on primary headache. Headache (2006) 1.05
Topiramate improves health-related quality of life when used to prevent migraine. Headache (2005) 1.03
The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia (2002) 1.02
Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Headache (2007) 1.01
The comorbidity of headache with other pain syndromes. Headache (2006) 1.00
The cycle of migraine: patients' quality of life during and between migraine attacks. Clin Ther (2007) 0.98
Pain control by vagus nerve stimulation: from animal to man...and back. Acta Neurol Belg (2005) 0.97
Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv (2005) 0.97
Fatigue in chronic migraine patients. Cephalalgia (2002) 0.97
Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily. Cephalalgia (2002) 0.97
Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. Headache (2006) 0.94
A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. Clin Neurol Neurosurg (2008) 0.94
Epidemiology of headache in Arab countries. J Headache Pain (2009) 0.92
Long-term results of migraine prophylaxis with flunarizine and beta-blockers. Cephalalgia (1991) 0.92
Fibromyalgia is common in patients with transformed migraine. Neurology (2001) 0.91
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes (2007) 0.91
Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study. Clin Drug Investig (2006) 0.90
Treatment recommendations for migraine. Nat Clin Pract Neurol (2008) 0.88
Feverfew for migraine prophylaxis. Headache (2006) 0.88
Prophylactic pharmacotherapy for migraine headaches. Semin Neurol (2006) 0.88
5-HT2 receptor antagonists and migraine therapy. J Neurol (1991) 0.87
Treatment of chronic migraine with medication overuse: is drug withdrawal crucial? Neurol Sci (2009) 0.86
Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Headache (2007) 0.86
Noradrenergic agonists and antagonists influence migration of cortical spreading depression in rat-a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage. J Cereb Blood Flow Metab (2005) 0.85
Pathophysiological basis of migraine prophylaxis. Prog Neurobiol (2009) 0.85
A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis. Headache (1990) 0.84
Occipital nerve stimulation for headache: mechanisms and efficacy. Headache (2008) 0.83
Sanomigran for migraine prophylaxis, controlled multicenter trial in general practice. Headache (1977) 0.83
Update on the prophylaxis of migraine. Curr Treat Options Neurol (2008) 0.83
[Therapy of the acute migraine attack and migraine prophylaxis. Recommendation of the "Deutsche Migräne- und Kopfschmerz-Gesellschaft]. Schmerz (2000) 0.83
Botulinum toxin in migraine prophylaxis. J Neurol (2004) 0.81
"Natural" or alternative medications for migraine prevention. Headache (2006) 0.81
Cost-effectiveness of antiepileptic drugs in migraine prophylaxis. Headache (2002) 0.81
Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study. Headache (2008) 0.81
Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache (2010) 0.81
Effectiveness of nonpharmacologic treatment for migraine in young children. Headache (2009) 0.80
Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial. Funct Neurol (1998) 0.80
Topiramate as an adjunctive treatment in migraine prophylaxis. Headache (2003) 0.80
[Antidepressants in migraine prophylaxis]. Brain Nerve (2009) 0.80
Therapeutic neurostimulation in chronic headaches: problems of patient selection. Neurol Sci (2008) 0.80
Selective serotonin reuptake inhibitors for migraine prophylaxis. Headache (1999) 0.79
'Ictal epileptic headache': recent concepts for new classifications criteria. Cephalalgia (2012) 3.19
Lifting the burden: the first 7 years. J Headache Pain (2010) 2.55
New policies to consolidate the journal's hold on its latest position. J Headache Pain (2009) 2.33
Mental illness in homicide-suicide: a review. J Am Acad Psychiatry Law (2012) 2.16
A tier-upon-tier march towards the impact factor. J Headache Pain (2008) 2.09
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
While climbing the hill, you think it's possible. J Headache Pain (2009) 1.97
Headache disorders are third cause of disability worldwide. J Headache Pain (2015) 1.93
Furnham's Money Attitude Scale. Psychol Rep (2002) 1.91
The content of suicide notes from attempters and completers. Crisis (2007) 1.86
Recalculating the economic cost of suicide. Death Stud (2007) 1.79
Association between carrier screening and incidence of cystic fibrosis. JAMA (2009) 1.78
The Journal of Headache and Pain keeps gaining consensus. J Headache Pain (2010) 1.70
Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain (2009) 1.60
The Global Campaign, World Health Organization and Lifting The Burden: collaboration in action. J Headache Pain (2011) 1.52
Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important. Intern Emerg Med (2015) 1.52
Precursors of bipolar disorders: a systematic literature review of prospective studies. J Clin Psychiatry (2015) 1.49
Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse? Intern Emerg Med (2010) 1.49
Time to act on headache disorders. J Headache Pain (2011) 1.47
Integration of suicidology with general medicine: an obligation to society. Patient Educ Couns (2011) 1.42
Natural suicide rates in nations of the world. Crisis (2004) 1.42
Blood type and bipolar disorder. Percept Mot Skills (2002) 1.40
Comment on the Werther effect. Crisis (2006) 1.40
Hemochromatosis-induced bipolar disorder: a case report. Gen Hosp Psychiatry (2011) 1.40
The definitive position of headache among the major public health challenges. An end to the slippery slope of disregard. J Headache Pain (2007) 1.40
Shibari: double hanging during consensual sexual asphyxia. Arch Sex Behav (2012) 1.39
Menstruation and suicide: an exploratory study. Psychol Rep (2007) 1.39
Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain (2013) 1.39
Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain (2011) 1.39
Sibship size, birth order, and personality. Psychol Rep (2005) 1.38
Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience. J Headache Pain (2006) 1.38
Factorial structure of the manic-depressiveness scale in American college students. Psychol Rep (2005) 1.37
Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat (2010) 1.37
Headache and emergency medicine: sharing a language for a common project. Intern Emerg Med (2008) 1.36
Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. Am J Psychiatry (2009) 1.35
Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain (2014) 1.31
Effect of balance training on postural instability in patients with idiopathic Parkinson's disease. Neurorehabil Neural Repair (2010) 1.30
Psychometric properties of the stagnation scale in medication overuse headache patients. J Headache Pain (2015) 1.29
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res (2008) 1.26
The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence. CNS Drugs (2012) 1.26
Suicide among Italian adolescents: 1970-2002. Eur Child Adolesc Psychiatry (2009) 1.26
Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry (2007) 1.25
Indications for electroconvulsive treatment in schizophrenia: a systematic review. Schizophr Res (2013) 1.22
Psychological tensions found in suicide notes: a test for the strain theory of suicide. Arch Suicide Res (2008) 1.22
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain (2011) 1.22
Post-traumatic stress disorder and suicide risk: a systematic review. Arch Suicide Res (2010) 1.21
Epidemiology of suicide in bipolar disorders: a systematic review of the literature. Bipolar Disord (2013) 1.19
Framing education on headache disorders into the Global Burden of Disease Study 2010. The European Headache Federation stands ready. J Headache Pain (2013) 1.19
Chronicling the June conundrum. J Headache Pain (2011) 1.18
The Global Burden of Disease survey 2010, Lifting The Burden and thinking outside-the-box on headache disorders. J Headache Pain (2013) 1.17
Suicidal behavior and alcohol abuse. Int J Environ Res Public Health (2010) 1.15
Do stroke patients have an increased risk of developing suicidal ideation or dying by suicide? An overview of the current literature. CNS Neurosci Ther (2012) 1.13
Psychotic-like experiences and correlation with distress and depressive symptoms in a community sample of adolescents and young adults. Schizophr Res (2010) 1.11
The impact of gun control (Bill C-51) on suicide in Canada. Death Stud (2003) 1.11
Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs (2012) 1.10
A six year retrospective review of occipital nerve stimulation practice--controversies and challenges of an emerging technique for treating refractory headache syndromes. J Headache Pain (2013) 1.09
Using google searches on the internet to monitor suicidal behavior. J Affect Disord (2012) 1.09
Suicide in borderline personality disorder: a meta-analysis. Nord J Psychiatry (2005) 1.07
The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention. Eur Arch Psychiatry Clin Neurosci (2010) 1.07
A psychometric investigation of the Suicide Opinion Questionnaire. Death Stud (2008) 1.07
Framing comorbidities and co-occurrences in a migraine with aura patient. Intern Emerg Med (2014) 1.07
Life events as precipitants of suicide attempts among first-time suicide attempters, repeaters, and non-attempters. Psychiatry Res (2011) 1.07